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DISSECTIONAcute aortic syndromeSteven L. Lansman, MD, PhD, Paul C. Saunders, MD, Ramin Malekan, MD, and David Spielvogel, MDThe term acute aortic syndrome refers to a heterogeneous group of conditions that cause a common set of signs and symptoms,
the foremost of which is aortic pain. Various pathologic entities may give rise to this syndrome, but the topic has come to focus
on penetrating aortic ulcer and intramural hematoma and their relation to aortic dissection. Penetrating aortic ulcer is a focal
atherosclerotic plaque that corrodes a variable depth through the intima into the media. Intramural hematoma is a blood
collection within the aortic wall not freely communicating with the aortic lumen, with restricted flow. It may represent a sub-
category of aortic dissection that manifests different behavior by virtue of limited flow in the false lumen. This article reviews
the current literature regarding acute aortic syndrome, focusing on management options. (J Thorac Cardiovasc Surg
2010;140:S92-7)The term acute aortic syndrome (AAS), coined by Vilacosta
and associates1,2 in 1998, refers to a heterogeneous group of
conditions that cause a common set of signs and symptoms,
the foremost of which is aortic pain. The pain is acute,
severely intense—often maximally so at its outset—and
may be described as tearing, ripping, migrating, or
pulsating. Hirst, Johns, and Kime3 state: ‘‘The patient will
frequently volunteer the information that it feels as if ‘some-
thing has broken loose’ in the chest.’’ Various diseases may
cause this striking presentation, including trauma, pseudoa-
neurysm, and ruptured atherosclerotic aneurysm, but the
term has come to subsume penetrating aortic ulcer (PAU),
intramural hematoma (IMH), and aortic dissection (AD).
One might ask whether a special category is needed for these
entities, but the term does seem to serve a function; like
‘‘acute coronary syndrome’’ and ‘‘acute abdomen,’’ it iso-
lates a set of pathologic conditions that may be unrelated eti-
ologically but nonetheless have a similar presentation and
require emergency attention.PENETRATING AORTIC ULCER (PAU)
PAU, initially described by Shennan4 in 1934, is a focal
atherosclerotic plaque that corrodes a variable depth through
the internal elastic lamina into the media. It may form a pseu-
doaneurysm or may rupture into the media, forming an IMH
in the media5,6 or between the media and adventitia.4,6,7 The
hematoma may propagate locally or, rarely, may give rise to
classic AD.
PAUs tend to occur in older men.8-10 The lesions may be
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S92 The Journal of Thoracic and Cardiovascular Surgand associates11), are predominantly situated in the descend-
ing aorta,9,12 but less frequently occur in the arch1,13-15 or
abdominal15,16 segments, and rarely in the ascending
aorta.1,8,13-15 In the Mayo Clinic series,8 patient characteris-
tics included hypertension (92%), tobacco use (77%), and
coronary artery disease (46%); 75%were symptomatic, usu-
ally with back pain, and 30% had pleural effusions. Chronic
obstructive pulmonary disease is common (24% in theMayo
series8; 68.4% in Botta and associates’ series11), as are con-
current aneurysms, particularly in the abdomen (42.1% in
the Yale series10; 61% in the Mayo series8).
PAU is best diagnosed by contrast-enhanced computed
tomographic (CT) scan or magnetic resonance imaging, ap-
pearing as a focal, contrast-filled outpouching with irregular
margins, and extending beyond the expected aortic wall
boundaries. It generally occurs in the presence of severe ath-
eromatous disease.5,17,18
The incidence of PAU in AASs ranges from 2.3% to
11%.19 In Hirst and Barbour’s comprehensive autopsy se-
ries,20 4.6% (18/398) of dissections originated from PAUs.
The prevalence of PAU is unknown but may be less than
once suspected, inasmuch as the widespread use of coronary
CT scans has not uncovered large numbers of incidental
cases.21One recent study revealed only 2 PAUs in 966 cardiac
CT coronary angiograms,21 and another found but 1 PAU in
395 CTs obtained for suspected acute coronary syndrome.22Management of PAU
Conflicting reports about the natural history of PAU have
led to opposing management strategies. Concerned with the
‘‘potentially progressive and serious nature’’ of PAU, Stan-
son and his colleagues13 at the Mayo Clinic in 1986 initially
adopted an aggressive stance, but their approach changed as
conservative therapy proved successful23: in 105 cases, 30-
day mortality for medical and surgical treatment was 4%
and 21% (P<.05). Moreover, in 89%, mean IMH thickness
decreased by 1 month, completely resolving by 1 year in
85%, and only 6 patients needed late surgery for aortic ex-
pansion.8 Hussain and associates24 also reported a benign
course for PAU in 5 patients: although 4 were symptomatic,
all survived without surgery, with complete resolution in 4.ery c December 2010
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Lansman et al Aortic Symposium 2010A CT study evaluating 56 PAUs in 38 patients did not re-
veal any feature predictive of lesion progression, although
pleural effusion did correlate with clinical instability.15
Only 30% progressed, manifesting a mild–moderate in-
crease in lesion size, aortic diameter, or both, whereas
76% were asymptomatic, with clinically stable lesions.
Thus, on the basis of satisfactory results with a conservative
approach, a number of authors have recommended initial
supportive therapy for PAU, with surgery reserved to treat
or prevent rupture, as indicated by persistent pain or enlarg-
ing PAU or aortic size.
PAU proved less benign in other series. For example,
Harris and colleagues,16 monitoring 17 ulcers in 10 patients,
reported distal embolization in 1 and progression to fusiform
or saccular aneurysm formation in 12% and 29%. The Yale
group reported that 40% of 15 medically managed patients
needed emergency surgery for rupture.14 An updated review
of their series, showing rupture in 38%, surgical interven-
tion in 65%, and hospital mortality in 15%, reinforced their
advocacy of aggressive management for PAU.25 The Stan-
ford group also advocated an aggressive approach on the ba-
sis of their experience with 65 IMH cases, wherein
progression with and without PAU was 48% and 8% and
medical management resulted in 10% mortality.26 Predic-
tors of progression included sustained or recurrent pain
(P< .0001), increasing pleural effusion (P ¼ .0003), and
both the maximum PAU diameter (P¼ .004) and maximum
PAU depth (P ¼ .003), with recommended threshold values
of 20 mm for PAU diameter and 10 mm for PAU depth.Endovascular Treatment of PAU
Whether PAUs are initially treated more or less aggres-
sively, both camps advocate intervention for clear-cut indi-
cations of pending or actual rupture, and over the past
decade endovascular treatment has emerged as an attractive
option. PAU comprised 7.1% of a series of 113 consecutive
patients with acute disease in the Talent Thoracic Retrospec-
tive Registry.27 One might think endograft therapy an attrac-
tive setting for PAU, inasmuch as most are isolated and
localized in a relatively normal-sized aorta, but there are
a number of caveats. First, PAU occurs in an older group
having significant comorbidities, often including chronic
obstructive pulmonary disease, coronary artery disease,The Journal of Thoracic and Carand renal insufficiency. Also, apparently isolated PAUs
often arise in a diffuse atherosclerotic setting, which may
increase the incidence of type I endoleaks—18% in a recent
series.11 Luminal irregularity may therefore necessitate
more extensive endografting than anticipated and—as op-
posed to atherosclerotic aneurysms, where intercostal
branches are often thrombosed—intercostal vessels may
be patent in PAU, increasing the risk of paraplegia by endog-
raft occlusion.12
Nonetheless, endograft treatment of PAU has yielded ex-
cellent perioperative results for these high-risk patients. The
Stanford group reported 94% primary success in 26 patients,
with 12% 30-day mortality and 0% paraplegia, although
half of the PAUs were deemed inoperable and 6 were rup-
tured7; however, underscoring the significance of comorbid-
ities, the 5-year survival was only 70%. Similarly, Botta and
coworkers,11 with 0% intraoperative mortality in 19 cases,
and Eggebrecht and colleagues,28 with 0% 30-day mortality
in 22 cases, reported 5-year survivals of 66.7% and 62%.
Criteria for endograft placement in the acute setting, ad-
vanced by Botta’s group,11 include pain and rupture; in
chronic cases, indications include recurrent pain, aortic di-
ameter greater than 55 mm, and increase in size greater
than 10 mm per year.
INTRAMURAL HEMATOMA (IMH)
IMH, first described by Krukenberg29 in 1920, has been
described as ‘‘dissection without intimal tear.’’ Histologi-
cally, the hematoma generally extends within the media,
but it may be subadventitial.6 On diagnostic imaging, IMH
appears as a smooth, crescentic, or circular thickening
greater than 5 to 7 mm. With expansion, the hematoma
may encroach on the aortic lumen and, if intimal calcium
is present, displace it centrally. Transthoracic or transeso-
phageal echocardiography may demonstrate IMH, but mul-
tidetector CT is the best diagnostic modality, inasmuch as it
can image the entire aorta and branch vessels.18
IMH comprises 10% to 30% of AAS.6 The patients tend
to be older,10 and most are hypertensive.10,30-33 In the
International Registry of Aortic Dissection database, IMH
was more common in the descending aorta (60.3%) than
the ascending aorta (39.7%).32 Type A IMH is often compli-
cated by pericardial effusion (47%34–68.3%33), pleural ef-
fusion (49%33) and aortic insufficiency (11.9%33–21%34).
Interestingly, Marfan syndrome (1%)33 and bicuspid aortic
valve were uncommon in many series.
Mechanism and Definition
It is commonly held that AD arises from an intimal tear,
whereas IMH arises from ‘‘rhexis’’ of the vasa vasorum,
without an intimal tear.5 However, the issue has long been
debated, and many hold that a single mechanism gives rise
to both entities; some believe that IMH represents AD
with a thrombosed false lumen, whereas others believediovascular Surgery c Volume 140, Number 6S S93
FIGURE 1. Relationship between flow, medial resistance, and aortic dis-
eases. DH,Discrete hematoma; IMH, intramural hematoma; PAU, penetrat-
ing aortic ulcer; AD, acute dissection; vv, vasa vasorum; BP, blood pressure;
dP/dt, rate of pressure rise.
Aortic Symposium 2010 Lansman et alIMH represents intramedial hemorrhage, without rupture
into the true lumen. Hirst and associates,3 who found 21
(4%) IMHs in their 1958 review of 504 AD cases, supported
the latter theory, noting, ‘‘The concept of initiation of aortic
dissection by rupture of the vasa vasorum is not new, having
been favored by Krukenberg in 1920.’’ As evidence, they
cited necropsy reports of hematomas without tears (and tears
without hematomas) going back to 1936. IMH may also
arise from trauma,35 or rupture of a PAU into the media.4
Krukenberg26,29 described IMH as ‘‘dissection without
tear,’’ but a number of studies emphasize the prevalence of
tears in supposed cases of IMH. For example, Park and
colleagues36 found intimal tears on retrospectively reviewed
preoperative CTs in 48.6% of 37 cases and in 73% at surgery;
in 67%, the defectswere located in the archor distal ascending
aorta, emphasizing the need to inspect the aorta during circu-
latory arrest.37 Similarly, Svensson and coworkers38 de-
scribed a localized, ‘‘discrete’’ hematoma that is difficult to
image, inasmuch as it is associated with a small intimal tear;
these lesions were found in 5% of a series of ascending and
arch replacements38 and 7.3% of a series of type A ADs.39
Confounding the issue, intimal tears can arise secondarily,
as derivative events in the development of an IMH.15,40
They may occur as the fragile, unsupported intimal layer is
subjected to shear forces; alternatively, they may be
caused by differential compliances of the outer and inner
layers38 or may represent a decompression mechanism for
the expanding hematoma.6S94 The Journal of Thoracic and Cardiovascular SurgAlthough authors may disagree on the role of intimal
tears, it is widely held that disease of the media is necessary
for propagation to occur.3,23 After all, worldwide, intimal
tears are created during aortic cannulation in over 1
million cases annually, but rarely result in AD. Normal or
fibrosed media may prohibit or retard IMH and AD
propagation, whereas abnormal media, as in medial
necrosis or Marfan syndrome, may potentiate propagation.
Broadly speaking, propagation or flow in the media is
governed by 2 factors: the magnitude of the source, be it
vasa vasorum or an intimal tear, and the resistance to flow
in the media (Figure 1). If, in concert, these factors yield re-
stricted flow, then thrombosis occurs and a discrete hema-
toma or IMH ensues; conversely, a large source of blood
with low medial resistance will result in AD.
The debate about IMH etiology may have shifted focus
from its essential aspect, which is that restricted flow in
the media gives rise to its characteristic behavior.33 A func-
tional definition of IMH, from the perspective of flow, is that
IMH is a blood collection within the aortic wall, not freely
communicating with the lumen, with restricted flow. Thus,
the epigram ‘‘dissection without intimal tear’’ becomes
‘‘dissection with restricted flow.’’ This definition of IMH
has the virtue of removing the impossible task of proving
a negative23 (the absence of an intimal tear) while focusing
on a positive (flow in the false lumen) that probably bears
more directly on its behavior.
Incidence and Natural History of IMH
Controversy regarding the natural history of IMH stems
from very different experiences with the prognosis and
even the incidence of IMH between centers in North Amer-
ica and Europe, and centers in Japan and Korea.
The incidence of IMH in the International Registry of
Aortic Dissection database,32 comprising data from many
Western centers, was 6% (58/1010), whereas in 2 large re-
cent Eastern series of type A AD, type A IMH comprised
28.3%33 and 29%.41 A meta-analysis of international expe-
rience confirmed that the incidence of type A IMH is lower
in North America/Europe (10.9%) than in Japan/Korea
(31.7%; P< .0001).42
IMH is known to be a dynamic entity: it may regress,
progress to classic AD, expand, or rupture, and these tenden-
cies also seem to vary geographically. For example, the Yale
group observed resolution in 19%,25 whereas a Korean
study showed resorption in 67% (24/36) with type A IMH
and 78% (54/69) with type B IMH.43 Similarly, reports of
progression or malignity have tended to vary along East–
West lines. The Yale group reported expansion or rupture
in 47.1% of 17 cases, with only 50% of patients surviving
to hospital discharge,10 and a group of Western centers re-
ported early progression in 45% of 66 IMH cases, with
20% mortality, and late progression in 21%, with 17%
mortality.44 In Eastern series, the rate of progression wasery c December 2010
Lansman et al Aortic Symposium 2010not necessarily less, but outcomes have been more favor-
able. For example, in a recent Japanese series of 50 type A
IMH cases, early and late progression was 30% and 10%,
but the overall mortality was only 4%.41
Management of IMH
Divergent clinical experiences have led to contrasting
recommendations for IMH management from Western
and Eastern centers. The Stanford group, based on an early
experience with 13 patients, recommended adopting the
strategy used for AD: surgery for type A IMH and initial
medical treatment for type B.30 Nienaber and associates45
reported that early mortality with and without surgery was
0% (0/7) versus 80% (4/5; P< .01); a group of Western
centers reported 8% versus 55% (P ¼ .004),44 and
a meta-analysis of 143 type A IMH cases from primarily
(13/19) Western centers showed 14% versus 36%
(P< .02).31 In contrast, a recent meta-analysis of 328 cases
of type A IMH from primarily (9/12) Asian centers showed
no difference in early mortality between surgical (10.1%
[17/168]) and medical (14.4% [23/160]) strategies
(P ¼ .37).34 Also, the recent meta-analysis comparing
Eastern versus Western reports for type A IMH yielded
mortality rates of 9.4% versus 20.6%, attributed in part
to the lower mortality with early medical therapy (7.8%
vs 33.3%; P< .0001).42
Two recent large single-center Asian experiences support
a conservative approach. Kitai and associates41 treated 50 of
66 patients with type A IMH (PAU and ulcer-like projection
[ULP] excluded) with medical therapy plus ‘‘timely’’ sur-
gery. Early mortality for the medical and surgical groups
was 4% and 6%. Thirty-two (64%) were discharged with-
out requiring surgery, with 0% late mortality related to
IMH or delayed surgery. Follow-up CT scans, available
in 31, showed complete resolution in 30, with significant re-
ductions in maximum hematoma thickness (9  4 mm to
0  1 mm; P< .001) and aortic diameter (45  4 mm to
42  6 mm; P ¼ .001). Survival at 1, 5, and 10 years
was 96%, 94%, and 89%.41 Another series, reporting
357 consecutive cases of type A AAS, described ‘‘timed’’
surgery in 101 type A IMH cases (PAU excluded). Sixteen
unstable patients had emergency surgery, with 12.5% (2/
16) mortality, and 85 received medical therapy, with
7.1% (6/85) hospital mortality. ‘‘Timed’’ surgery was per-
formed on 17 before discharge and 8 after discharge, with
4% (1/25) overall mortality. Sixty-two (80%) observed pa-
tients were discharged home without requiring surgery. Sur-
vival was the same for medical and surgical groups: 87.6%
and 83.1% at 1 and 3 years.33 Although these results are
quite good from a population standpoint, 6 patients with
probably very low operative risk died suddenly while under
observation. Of note in this regard is the recent Japanese re-
port of 41 surgically treated patients with type A IMH, with
0% hospital mortality and 100% 5-year survival.46The Journal of Thoracic and CarThus, a spectrum of IMH with restricted medial flow,
thrombosis, and a more benign course occurs more
frequently in the Asian population, but the divergence
between Eastern and Western experiences has not been
explained. In light of success with the Eastern approach,
some Western centers are cautiously adopting a more con-
servative strategy. For example, Estrera and associates47
reported an intermediate approach with timely but not imme-
diate surgery in 36 patients with type A IMH, from a series
of 251 patients with acute type A AD. Immediate surgery
was performed in 7, with 14.3% (1/7) mortality, and 28
(80%) underwent timely surgery, with 7.1% (2/28) mortal-
ity. During observation, 33% (12/36) of type A IMHs
converted to AD, but none within the first 72 hours. Of inter-
est, the 1 medically managed patient—of Asian ethnicity—
survived, with full resolution.47 The authors believed that
deferring emergency surgery permitted the aortic wall to
thicken, facilitating repair, and allowed the extensive, acute
inflammatory response to subside.
Predictors of IMH Behavior
A significant number of IMHs in series of ‘‘timed’’ or
‘‘timely’’ surgery progressed, in terms of expansion, AD,
or death, permitting predictors of progression to be identi-
fied. For type B IMH, age older than 70 years and the appear-
ance of ULPs strongly predicted progression.48 In Kitai and
associates’41 study of type A IMH, cardiac tamponade was
a univariate risk factor and maximum hematoma thickness
of 10 mm or more was identified as a cutoff for predicting
progression, but only aortic diameter of 50 mm or more pre-
dicted progression by multivariate analysis. Aortic diameter
of 55 mm or more was identified as a significant predictor of
progression in Song and colleagues’33 recent publication, as
well as IMH thickness greater than 16 mm.
Other ominous signs include persistent pain, the presence
of PAU,41 the appearance of ULPs,33,41 malperfusion,33,47
and indications of proximal root involvement, including
aortic insufficiency41 and a large pericardial effusion or car-
diac tamponade.41
On the basis of these and similar studies, conservative cri-
teria for initial observation of type A IMH and for proceed-
ing to ‘‘timed’’ surgery can be synthesized (Table 1).
Observing patients with type A IMH may be difficult to
put into practice in many centers, inasmuch as some regi-
mens require in-hospital observation for at least 30 days.
One protocol calls for initial CT and transesophageal echo-
cardiographic studies to rule out PAU, ULP, or AD; daily
transthoracic echocardiographic examinations for the fol-
lowing 5 days to monitor for new ULP, aortic insufficiency
and enlarging aortic diameter, IMH thickness or pericardial
effusion; and follow-up transesophageal echocardiography
or CT imaging after 3 days and then weekly through the third
week.41 Although the risk of progression and adverse events
is high early in the course of IMH,47 sudden death afterdiovascular Surgery c Volume 140, Number 6S S95
TABLE 1. Type A IMH criteria
Criteria for observation
Hemodynamically stable
No persistent pain
Aortic diameter  50 mm
Hematoma thickness  10 mm
No PAU or ULP
Small pericardial/pleural effusion and no tamponade
No aortic insufficiency
Criteria for ‘‘timed’’ intervening surgery
Pain
New ULP
Progression to AD
Increasing IMH thickness
Increasing aortic diameter
Increasing pericardial/pleural effusion or tamponade
No regression
IMH, Intramural hematoma; PAU, penetrating aortic ulcer;ULP, ulcer-like projection;
AD, aortic dissection.
Aortic Symposium 2010 Lansman et alhospital discharge can occur,33 and protocols for long-term
monitoring are not fully established.CONCLUSIONS
AAS refers to a heterogeneous group of conditions that
cause a common set of signs and symptoms, the foremost
of which is aortic pain, and it subsumes PAU and IMH. Di-
vergent clinical experiences with these entities have led to
opposing views of their malignity and, hence, contrasting
recommendations for management. Endovascular repair
has become the treatment of choice for appropriate PAU
cases, and some have cautiously adopted a conservative ap-
proach, reserving ‘‘timed surgery’’ for type A IMH.References
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